Navigation Links
DePuy ASR Hip Lawsuit Judge Upholds $8.3 Million Verdict in Nation’s First Trial Stemming from 2010 DePuy ASR Recall, Bernstein Liebhard LLP Reports
Date:5/28/2013

New York, New York (PRWEB) May 28, 2013

Bernstein Liebhard LLP notes that the California judge overseeing the nation’s first DePuy ASR lawsuit trial has rejected Johnson & Johnson’s motions for a new trial and a judgment notwithstanding the verdict. In March, the jury hearing the DePuy ASR recall lawsuit in Los Angeles Superior Court found the hip was defectively designed, and awarded more than $8.3 million to the Plaintiff. In a ruling handed down on May 24th, Judge J. Stephen Czuleger upheld the jury’s decision, finding the Plaintiff had provided enough evidence to show the recalled metal-on-metal hips were defectively designed. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County)

“We are extremely pleased with this ruling, and agree that the Plaintiff in this case convincingly proved that the ASR was defectively designed. Our Firm is confident that future DePuy ASR lawsuit trials will result in equally favorable verdicts for claimants,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR hip lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Hip Lawsuits
Court records indicate that there are more than 10,000 DePuy ASR hip lawsuits currently pending throughout the U.S, most of which have been filed in a multidistrict litigation underway in U.S. District Court, Northern District of Ohio. The first trials in this proceeding are expected to begin in September 2013. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

Court documents indicate that during the recently-concluded trial in Los Angeles, evidence was introduced that indicated that Johnson & Johnson and its DePuy Orthopaedics unit knew that the ASR was defective years before the recall was announced. However, that information was not shared with the public or the medical community. According to a New York Times report published on April 16th, much of the same evidence was introduced in a second trial that concluded last month in Illinois state court. However, the jury hearing that case found for Johnson & Johnson.* (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County)

The DePuy ASR hip recall was announced in August 2010, after the metal-on-metal hip implants were found to be failing in 12-13% of recipients within just five years of implantation. Since then, the entire class of metal-on-metal hip implants has come under scrutiny, with the U.S. Food & Drug Administration (FDA) recently proposing new rules that would subject the devices to greater regulatory oversight.**

Bernstein Liebhard LLP is actively filing DePuy ASR lawsuits in the federal litigation underway in Ohio, and continues to offer free legal reviews to individuals who suffered metallosis, premature device failure or other complications allegedly related to the DePuy ASR. A wealth of information regarding DePuy ASR hip lawsuits is available on Bernstein Liebhard LLP’s website. For a free case review, please contact one of our attorneys by calling 800-511-5092.

*nytimes.com/2013/04/17/business/johnson-johnson-wins-case-on-artificial-hip.html?ref=health&_r=0
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm; FDA January 17, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-asr-verdict/prweb10775527.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case
2. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation
3. DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP
4. Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products
5. DePuy Pinnacle Hip Implant Lawsuit News: Bernstein Liebhard LLP Comments on Johnson & Johnson Decision to Stop Metal-on-Metal Hip Sales
6. DePuy ASR Lawsuit Update: Rottenstein Law Group Comments on Delay of Second Federal Trial
7. DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Rescheduling of First Bellwether Trial in Federal DePuy ASR Litigation
8. Alleged DePuy Knee Sleeve Failure Lawsuits Now Being Reviewed by Resource4thePeople Attorneys
9. DePuy ASR Lawsuit Update: Rottenstein Law Group Addresses J&J Motion to Appeal $8.3 Million Verdict
10. DePuy ASR Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Hip Recall Litigation
11. California Jury Awards Man $8 Million after Injured by Defective DePuy ASR Hip Implant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an informative and ... one hour a week showing of hands. “The Road To Restoration” is the creation ... are familiar with the brass ring that you could reach out for, and grab, ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Walking With God: Inspirational Lessons from My Life's ... reader to be aware of God's direction in their lives. “Walking With God: Inspirational ... teacher and active church leader. , Sanford says, “I enjoy sharing the ...
(Date:12/7/2016)... 3, 2016) , ... (PRWEB) December 07, 2016 ... ... patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was awarded a ... Mexico with a patient engagement program. New Mexico has more people with cavernous ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... present at the International Probiotic Association’s Washington DC workshop on November 2nd. The ... engage in dialog regarding probiotic dietary supplement regulations. , Dr. Leyer spoke ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Hacking into my medical record ... him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in the ... Wyston Books, Inc. These novels narrate the lives of a poor teenager ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... company focused on delivering scientific and medical breakthroughs ... Chairman and Chief Executive Officer Keith Murphy ... Wednesday, December 14, 2016 at 1:00 p.m. Eastern ... not yet familiar with the Company, an informational ...
(Date:12/7/2016)... , December 7, 2016 ... reach a value of USD 3.9 billion by ... View Research, Inc. The growth of the market ... and continuous technological advancements by the market players. ... due to increasing donation, rising awareness about transfusion-transmitted ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
Breaking Medicine Technology: